Progression-free survival as a potential surrogate endpoint for overall survival after conversion therapy for unresectable hepatocellular carcinoma (GUIDANCE008). - Wu JW; Yang DL; Chen SC; Li MJ; Liang YR; Wang XY; Yao HB; Liu J; Wu PS; Peng N; Nong JL; Yu YQ; et al. (Scientific reports, 2026)